![Jeffrey W. Jacobs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey W. Jacobs
Directeur Technique/Scientifique/R&D chez
FULCRUM THERAPEUTICS, INC.
Profil
Jeffrey W.
Jacobs currently works at Fulcrum Therapeutics, Inc., as Chief Scientific Officer from 2022.
Dr. Jacobs also formerly worked at Sunesis Pharmaceuticals, Inc., as Senior Director-Development Chemistry from 2000 to 2008, Affymax, Inc., as Senior Director-Development Chemistry, Vicuron Pharmaceuticals LLC, as Principal, The Damon Runyon Cancer Research Foundation, as Principal, Ardelyx, Inc., as Vice President-Medicinal Chemistry from 2008 to 2011, and Goldfinch Bio, Inc., as Chief Scientific Officer.
Dr. Jacobs received his undergraduate degree from Gonzaga University and doctorate degree from the University of California, Berkeley.
Postes actifs de Jeffrey W. Jacobs
| Sociétés | Poste | Début |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2022 |
Anciens postes connus de Jeffrey W. Jacobs
| Sociétés | Poste | Fin |
|---|---|---|
| ARDELYX, INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2008 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Directeur Technique/Scientifique/R&D | - |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Corporate Officer/Principal | - |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Formation de Jeffrey W. Jacobs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Gonzaga University
 Gonzaga University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
